NCT06603597 - HER2-positive Breast Cancer Registry | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

October 31, 2044

Study Completion Date

October 31, 2044

Conditions

HER2 + Breast Cancer

Trial Locations (6)

ACTIVE_NOT_RECRUITING

KUCC - Lee's Summit, Lee's Summit

ACTIVE_NOT_RECRUITING

KUCC - Briarcliff, Westwood

ACTIVE_NOT_RECRUITING

KUCC - Olathe, Westwood

RECRUITING

The University of Kansas Cancer Center, Westwood

ACTIVE_NOT_RECRUITING

KUCC - Indian Creek, Overland Park

ACTIVE_NOT_RECRUITING

KUCC - Overland Park, Overland Park